📣 VC round data is live. Check it out!

OssDsign Valuation Multiples

Discover OssDsign's revenue and EBITDA valuation multiples and M&A history, alongside public comparables like Mentice, Elutia, Biohit, Sensus Healthcare and more.

OssDsign Overview

About OssDsign

OssDsign AB is a developer and international provider of next-generation orthobiologics products. The company's product OssDsign Catalyst is a bone graft that stimulates the formation of healthy bone tissue in spinal fusion surgeries. Geographically the company generates revenue from the USA, Germany, Sweden, the UK, the Rest of Europe, and the Rest of world. The company generates the majority of its revenue from the USA.


Founded

2011

HQ

Sweden

Employees

27

Financials (LTM)

Revenue: $19M
EBITDA: ($5M)

EV

$27M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

OssDsign Financials

OssDsign reported last 12-month revenue of $19M and negative EBITDA of ($5M).

In the same LTM period, OssDsign generated $18M in gross profit, ($5M) in EBITDA losses, and had net loss of ($6M).

Revenue (LTM)


OssDsign P&L

In the most recent fiscal year, OssDsign reported revenue of $20M and EBITDA of ($4M).

OssDsign is unprofitable as of last fiscal year, with gross margin of 92%, EBITDA margin of (21%), and net margin of (27%).

See analyst estimates for OssDsign
LTMLast FY202320242025202620272028
Revenue$19M$20M$12M$14M$19M
Gross Profit$18M$19M$9M$14M$19M
Gross Margin95%92%75%95%96%
EBITDA($5M)($4M)($11M)($5M)($5M)
EBITDA Margin(24%)(21%)(91%)(31%)(26%)
EBIT Margin(26%)(22%)(82%)(37%)(27%)
Net Profit($6M)($5M)($14M)($5M)($5M)
Net Margin(29%)(27%)(116%)(37%)(28%)

Financial data powered by Morningstar, Inc.

OssDsign Stock Performance

OssDsign has current market cap of $45M, and enterprise value of $27M.

Market Cap Evolution


OssDsign's stock price is $0.41.

OssDsign share price decreased by 7.0% in the last 30 days, and by 73.6% in the last year.

OssDsign has an EPS (earnings per share) of $-0.05.

See more trading valuation data for OssDsign
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$27M$45M-6.2%-7.0%-40.8%-73.6%$-0.05

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

OssDsign Valuation Multiples

OssDsign trades at 1.4x EV/Revenue multiple, and (5.9x) EV/EBITDA.

See NTM and 2027E valuation multiples for OssDsign

EV / Revenue (LTM)


OssDsign Financial Valuation Multiples

As of June 4, 2026, OssDsign has market cap of $45M and EV of $27M.

OssDsign has a P/E ratio of (8.0x).

LTMLast FY202320242025202620272028
EV/Revenue1.4x1.3x2.3x1.9x1.4x
EV/EBITDA(5.9x)(6.5x)(2.5x)(6.0x)(5.5x)
EV/EBIT(5.5x)(6.1x)(2.8x)(5.1x)(5.3x)
EV/Gross Profit1.5x1.5x3.0x2.0x1.5x
P/E(8.0x)(8.3x)(3.2x)(8.5x)(8.3x)
EV/FCF(3.7x)(3.6x)(2.7x)(4.0x)(3.6x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified OssDsign Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

OssDsign Margins & Growth Rates

OssDsign decreased revenue by 11% but EBITDA grew by 26% in the last fiscal year.

In the most recent fiscal year, OssDsign reported gross margin of 92%, EBITDA margin of (21%), and net margin of (27%).

See estimated margins and future growth rates for OssDsign

OssDsign Margins

Last FY202420252026202720282029
Gross Margin92%95%96%94%
EBITDA Margin(21%)(31%)(26%)(29%)
EBIT Margin(22%)(37%)(27%)(31%)
Net Margin(27%)(37%)(28%)(31%)
FCF Margin(38%)(47%)(40%)(38%)

OssDsign Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth(11%)19%35%(7%)
Gross Profit Growth(9%)53%36%(9%)
EBITDA Growth26%(59%)10%6%
EBIT Growth26%(46%)(2%)9%
Net Profit Growth3%(62%)3%3%
FCF Growth(11%)(33%)13%(11%)

Data powered by FactSet, Inc. and Morningstar, Inc.

OssDsign Operational KPIs

OssDsign's revenue per employee in the last FY averaged $0.8M, while opex per employee averaged $0.9M for the same period.

OssDsign's Rule of 40 is (36%) (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

OssDsign's Rule of X is (46%) (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for OssDsign
LTMLast FY202320242025202620272028
Rule of 40(14%)(36%)---
Bessemer Rule of X1%(46%)---
Revenue per Employee-$0.8M---
Opex per Employee-$0.9M---
S&M Expenses to Revenue31%72%83%80%75%
G&A Expenses to Revenue31%35%45%33%36%
R&D Expenses to Revenue13%11%26%17%11%
Opex to Revenue-118%157%132%123%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

OssDsign Competitors

OssDsign competitors include Mentice, Elutia, Biohit, Sensus Healthcare, Baumer, InspireMD, Nutriband, Accuray, Baird Medical Investment and HeartBeam.

Most OssDsign public comparables operate across Medical Devices, HealthTech and DeepTech.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Mentice1.3x1.3x87.0x31.3x
Elutia1.8x1.8x(1.7x)(1.5x)
Biohit2.3x-10.9x-
Sensus Healthcare1.1x1.1x(3.0x)(2.9x)
Baumer0.8x-3.7x-
InspireMD1.0x0.9x(0.2x)(0.2x)
Nutriband14.2x14.2x(4.8x)-
Accuray0.4x0.5x6.8x63.8x

This data is available for Pro users. Sign up to see all OssDsign competitors and their valuation data.

Start Free Trial

OssDsign VC Funding History

Before going public, OssDsign raised $12M in total equity funding, across 2 rounds.


OssDsign Funding Rounds

DateStageRaised FromRaisedValuationRev. MultipleDeal Summary
Nov-15Series AAlmi Invest; Fouriertransform; Karolinska Development; SEB Venture Capital$10M--
Jul-13SeedKarolinska Development$2M--

Acquisitions by OssDsign

OssDsign has acquired 1 company to date.

Last acquisition by OssDsign was on November 3rd 2020. OssDsign acquired Sirakoss for $11M (EV/Revenue multiple available to Pro users).

See M&A valuation multiples

Latest Acquisitions by OssDsign

Sirakoss
Description
Sirakoss is an Edinburgh-based medical device developer of synthetic bone graft substitutes using MaxSi technology for trauma, spine, craniomaxillofacial, and dental surgeries. The firm produces granular and putty forms mimicking natural bone resorption rates, tested in preclinical models. Incorporated in 2011 as a University of Edinburgh spinout, it secured CE marking for its products.
HQ CountryUnited Kingdom
HQ City
Edinburgh
Deal Date3 Nov 2020
Valuation$11M
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all OssDsign acquisitions and their M&A valuation multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About OssDsign

When was OssDsign founded?OssDsign was founded in 2011.
Where is OssDsign headquartered?OssDsign is headquartered in Sweden.
How many employees does OssDsign have?As of today, OssDsign has over 27 employees.
Is OssDsign publicly listed?Yes, OssDsign is a public company listed on Nasdaq Stockholm.
What is the stock symbol of OssDsign?OssDsign trades under OSSD ticker.
When did OssDsign go public?OssDsign went public in 2019.
Who are competitors of OssDsign?OssDsign main competitors include Mentice, Elutia, Biohit, Sensus Healthcare, Baumer, InspireMD, Nutriband, Accuray, Baird Medical Investment, HeartBeam.
What is the current market cap of OssDsign?OssDsign's current market cap is $45M.
What is the current revenue of OssDsign?OssDsign's last 12 months revenue is $19M.
What is the current revenue growth of OssDsign?OssDsign revenue growth (NTM/LTM) is 10%.
What is the current EV/Revenue multiple of OssDsign?Current revenue multiple of OssDsign is 1.4x.
Is OssDsign profitable?No, OssDsign is not profitable.
What is the current EBITDA of OssDsign?OssDsign has negative EBITDA and is not profitable.
What is OssDsign's EBITDA margin?OssDsign's last 12 months EBITDA margin is (24%).
What is the current EV/EBITDA multiple of OssDsign?Current EBITDA multiple of OssDsign is (5.9x).
What is the current FCF of OssDsign?OssDsign's last 12 months FCF is ($7M).
What is OssDsign's FCF margin?OssDsign's last 12 months FCF margin is (38%).
What is the current EV/FCF multiple of OssDsign?Current FCF multiple of OssDsign is (3.7x).
How many companies OssDsign has acquired to date?As of June 2026, OssDsign has acquired 1 company.
What was the largest acquisition by OssDsign?$11M acquisition of Sirakoss on 3rd November 2020 was the largest M&A OssDsign has done to date.
What companies OssDsign acquired?OssDsign acquired Sirakoss.
In how many companies OssDsign has invested to date?OssDsign hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to OssDsign

Lists including OssDsign

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial